Canada’s Generex Biotechnology, through its Indian licensee Shreya Life Sciences, has submitted a dossier of recently concluded Phase III trial results of its oral insulin ‘Generex Oral-lyn’ to the Indian government for ...
Tags: Generex Biotechnology, Shreya Life Sciences, oral insulin
Wireless remote monitoring devices will be used by more than 1.8 million people worldwide in four years, representing a six-fold increase in adoption of telehealth technology, according to a new study by InMedica, part of research firm IHS. ...
TVM Life Science Ventures VII has made the first investment in Montreal-based Kaneq Bioscience, a spin out company of Kaneq Pharma. Kaneq Bioscience was created for developing a protein tyrosine phosphatase1B (PTP-1B) inhibitor, designed ...
Tags: TVM Life Science, Pharma, Kaneq Pharma
European Union has given its CE Mark approval for a diabetic wound management device developed by global medical devices firm Integra LifeSciences. The new device called Integra Flowable Wound Matrix 2 is a flowable version of Integra's ...
The European Commission has issued clearance to market Novo Nordisk's diabetes therapies, Tresiba and Ryzodeg, across 27 European Union (EU) states. Novo Nordisk anticipates launching Tresiba, brand name of insulin degludec, in the UK and ...
Tags: Ryzodeg diabetes drugs, injection doses, diabetes therapies
A Philips information management system, which is used in making administrative chores in hospital more efficient, contains vulnerabilities that can be exploited to gain full control of the product, a security vendor said on Thursday. ...
Clothing maker Primal is continuing its support of the American Diabetes Association and Tour de Cure on the national and state level. The company is now one of the ADA's four national sponsors, joining Gold's Gym, Lilly Diabetes and ...
GI Dynamics has a started a US pivotal trial of its non-surgical device, designed to treat patients with obesity and uncontrolled type 2 diabetes. Flexible, tube-shaped EndoBarrier device, which is implanted into the gut, forms a physical ...
Tags: GI Dynamics, EndoBarrier device, diabetes
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Hygieia's claims related to Diabetes Insulin Guidance system (DIGS) technology. The patent covers a system which automatically optimizes a patient's ...
Tags: USPTO, NOA, Hygieia, DIGS technology
If you haven't come down with the flu yet, there's still a good chance that you will. The Centers for Disease Control and Prevention says flu season is likely to last several more weeks, leading to fever, aches, headaches, and general ...
The United States spends twice as much per person on health care as the rest of the developed world, with little to show for it except shorter and unhealthier lives than citizens of its peer nations enjoy. That's the depressing conclusion ...
Tags: health, health care, Institute of Medicine, heath insurance
For almost two decades research has suggested that people with diabetes and multiple clogged arteries live longer and have fewer heart attacks if they undergo bypass surgery instead of angioplasty. Yet many of those people continue to be ...
Tags: diabetes, multiple clogged arteries, healthcare, heart attacks
One likely effect of the growing number of young people with type 2 diabetes is that more and more people in their 20s and 30s are developing serious eye problems not correctable with glasses. "We've all been aware that obesity and ...
Tags: diabetes, eye problems, eye health, eye diseases
Human breath contains a range of volatile organic components,which can help to provide useful information for diagnosis of various diseases,it has been found. The Korea Advanced Institute of Science and Technology has reached a new ...
Sagent Pharmaceuticals has announced the temporary importation of 8.4% Sodium Bicarbonate Injection, USP into the US market from Australia-based Phebra. The temporary arrangement is to address the present critical shortage of non-FDA ...
Tags: Sagent, Sodium Bicarbonate Injection, drug, drug shortage